Literature DB >> 11377119

A psychometric comparison of health-related quality of life measures in chronic liver disease.

G Unal1, J B de Boer, G J Borsboom, J T Brouwer, M Essink-Bot, R A de Man.   

Abstract

Four generic [the Sickness Impact Profile (SIP-68), Short-Form Health Survey (SF-36), EuroQol instrument (EQ-5D), COOP/WONCA charts], two domain-specific health-related quality of life measures [the sexuality scale of the HIV Overview Problems Evaluating System (HOPES), Multi-dimensional Fatigue Index (MFI-20)], and a self-developed 12-item symptom index were compared in terms of feasibility, test-retest reliability, internal consistency reliability, construct validity, and known groups validity in patients with chronic liver disease. All instruments could be completed within 10 min and exhibited a good psychometric performance in patients with chronic liver disease. The SF-36 and the MFI-20 performed relatively best in terms of reliability, construct validity, and discriminative ability. The sexuality scale of the HOPES demonstrated a relatively poor performance, as the missing value rate was higher than 5%. Further research is needed into the sensitivity to important clinical changes of the instruments.

Entities:  

Mesh:

Year:  2001        PMID: 11377119     DOI: 10.1016/s0895-4356(00)00372-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  22 in total

1.  Utility-based Quality of Life measures in Alzheimer's disease.

Authors:  Gary Naglie; George Tomlinson; Catherine Tansey; Jane Irvine; Paul Ritvo; Sandra E Black; Morris Freedman; Michel Silberfeld; Murray Krahn
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

2.  Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.

Authors:  A Jacoby; A Rannard; D Buck; N Bhala; J L Newton; O F W James; D E J Jones
Journal:  Gut       Date:  2005-06-16       Impact factor: 23.059

Review 3.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Validity and reliability of Persian version of Chronic Liver Disease Questionnaire (CLDQ).

Authors:  Hilda Mahmoudi; Peyman Jafari; Mahvash Alizadeh-Naini; Siyavash Gholami; Seyed Ali Malek-Hosseini; Sina Ghaffaripour
Journal:  Qual Life Res       Date:  2011-11-13       Impact factor: 4.147

5.  The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaire.

Authors:  Simone M van der Plas; Bettina E Hansen; Josien B de Boer; Theo Stijnen; Jan Passchier; Rob A de Man; Solko W Schalm
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

6.  Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt.

Authors:  Michaël Schwarzinger; Sahar Dewedar; Claire Rekacewicz; Khaled Mahmoud Abd Elaziz; Arnaud Fontanet; Fabrice Carrat; Mostafa Kamal Mohamed
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey.

Authors:  Simone M van der Plas; Bettina E Hansen; Josien B de Boer; Theo Stijnen; Jan Passchier; Rob A de Man; Solko W Schalm
Journal:  Qual Life Res       Date:  2006-11-25       Impact factor: 4.147

8.  Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease.

Authors:  C D Wells; W B Murrill; M R Arguedas
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

9.  BE-ACTIV for depression in nursing homes: primary outcomes of a randomized clinical trial.

Authors:  Suzanne Meeks; Kimberly Van Haitsma; Ben Schoenbachler; Stephen W Looney
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-04-01       Impact factor: 4.077

10.  Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.

Authors:  Axel C Mühlbacher; John F P Bridges; Susanne Bethge; Ch-Markos Dintsios; Anja Schwalm; Andreas Gerber-Grote; Matthias Nübling
Journal:  Eur J Health Econ       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.